Cleveland, OH, United States
Cleveland, OH, United States

Time filter

Source Type

The International Association of HealthCare Professionals is pleased to welcome Mohammad A. Bilal, MD, Interventional Radiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Mohammad A. Bilal is a highly trained and qualified radiologist with an extensive expertise in all facets of his work, especially percutaneous abdominal drainage and venous catheterization. Dr. Bilal has been in practice for more than 13 years and is currently serving as Director of Vascular and Interventional Radiology in Port Jefferson, New York. He is also affiliated with John T. Mather Memorial Hospital and Stony Brook University Hospital. Dr. Mohammad A. Bilal attended Boston University School of Medicine, where he graduated with his Medical Degree. Following his graduation, he subsequently completed his residency in Diagnostic Radiology and then fellowship in Vascular and Interventional Radiology at Long Island Jewish Medical Center. Dr. Bilal is board certified in Diagnostic, Vascular, and Interventional Radiology by the American Board of Radiology. To keep up to date with the latest advances in his field, he maintains professional memberships with the Society of Interventional Radiology, the Radiological Society of North America, the American Roentgen Ray Society, the American College of Radiology, the American Medical Association, the Suffolk County Medical Society, and the Medical Society of the State of New York. He attributes his success to his excellent training, interpersonal skills, patience, commitment, and his excellent support staff. In his free time, Dr. Bilal enjoys traveling, watching movies, and dining out. Learn more about Dr. Bilal by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Robert J. Schmall, MD, Diagnostic Radiologist to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Robert J. Schmall is a highly trained and qualified physician with an extensive expertise in all facets of his work, especially vascular and interventional radiology. Dr. Schmall has been in practice for 19 years and is currently serving patients within Radiology Consultants of Iowa in Cedar Rapids, Iowa. Dr. Schmall attended the University of Iowa College of Medicine in Iowa City, where he graduated with his Medical Degree in 1991. He subsequently undertook his residency training in Radiology at the Naval Medical Center San Diego. Then he completed his fellowship training in Vascular and Interventional Radiology at the University of Michigan. Dr. Schmall is board certified in Diagnostic Radiology by the American Board of Radiology. He also has his Certificate of Additional Qualification in Vascular and Interventional Radiology. To keep up to date with the latest advances and developments in his field, he maintains professional memberships with the Radiology Society of North America, the American College of Radiology, and the Society of Interventional Radiology. He attributes his success to his hard work, and when he is not assisting his patients, Dr. Schmall likes to relax by reading and spending time with his family. Learn more about Dr. Schmall here: http://www.rciowa.com/ and be sure to read his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | November 30, 2016
Site: globenewswire.com

TORONTO, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Dr. Patricio Stocker, President and CEO of PharmaCielo Ltd., announced the company has appointed a Medical Advisory Board (MAB) to provide guidance on the development of medicinal-grade cannabis oil extracts and related products appropriate for use by clinical practitioners. “Under the guidance of Dr. Delon Human, PharmaCielo Board of Directors member and Chair of the MAB, appointees will be able to provide significant input in the development of our medicinal-grade products through their ability to provide global expertise in the areas of healthcare policy, regulation, medical science and patient insights in addition to their clinical experience,” said Dr. Stocker. Dr. Human has assembled an experienced team of international medical clinicians whose expertise will be leveraged to provide guidance in the development of medicinal-grade cannabis oil based products, as well as international insight and understanding of worldwide healthcare policy and its implications for this emerging global industry. “The Medical Advisory Board will oversee PharmaCielo’s practices and processes, ensuring they are UN-aligned and performed ethically and according to Good Manufacturing and Good Medical Practice,” said Dr. Human.  “During the April 2016 UN General Assembly Special Session on Drugs, the UN and its member states strongly endorsed the need to ensure the accessibility and availability of internationally controlled drugs for medical and scientific purposes, including substances such as cannabinoids. In developing a global framework, this should be promoted within national legal systems, while simultaneously preventing diversion, abuse and trafficking. PharmaCielo has the opportunity to develop the world’s finest quality, naturally grown, pharma-grade cannabis oils.” Four appointees to the MAB were introduced (full biographies are available at www.pharmacielo.com): Dr. Delon Human is the president and CEO of Health Diplomats, a health advisory and consulting practice, providing strategic and technical advice on global health issues to Fortune 500 companies in the pharmaceutical, food, tobacco, nicotine and medical device industries as well as NGOs, governments and foundations. He has acted as adviser to WHO Director-Generals and UN Secretary-General Ban Ki Moon. He is a published author and specializes in global health strategy, corporate and product transformation, harm reduction and health communication. Formerly, he served as the Secretary-General of the International Food and Beverage Alliance (IFBA), which brings together the top food companies in the world. From 1997 to 2005, Dr. Human served as secretary general of the World Medical Association (WMA), the global representative body for physicians. He was instrumental in the establishment of the World Health Professions Alliance, an alliance of the global representative bodies of physicians, nurses, pharmacists, dentists and physical therapists. Dr. Human qualified as a physician in South Africa and completed his postgraduate studies in family medicine and child health in South Africa and Oxford, England. He was a clinician for two decades, part of the pediatric endocrinology research unit at the John Radcliffe Hospital and was involved in the establishment of several medical centers, a hospital and emergency clinic in South Africa. His business studies (MBA) were completed at the Edinburgh Business School. A former chair of the World Medical Association, Dr. Anders Milton is a highly sought-after consultant within the healthcare sector and has served as president of the European Regional Network on HIV/AIDS (ERNA) and as president of the Swedish Red Cross among a number of other positions, including appointment by the Swedish government as chairman of a committee on Swedish HIV/AIDS policies and a member of the Catastrophe Commission formed following the December 2004 tsunami. Recently he led a select committee studying organ donation and transplantation. Previously, Dr. Milton served as president and CEO of the Swedish Medical Association. A director of several public and privately held companies and foundations, Dr. Milton originally studied economics before turning to medicine, and after graduating university as a medical doctor and PhD he served as a clinician at the Department of Nephrology at the University Hospital at Uppsala. Throughout his career he has been engaged in work in support of human rights, ethics of medical practice and safe health care, of which effective pharmacotherapy is an integral part. Dr. Gutiérrez is a neuroradiologist in private practice and Director of the Neuroradiology Division at Centro Avanzado de Diagnostíco Médico (CEDIMED) in Colombia. Previously, Dr. Gutiérrez served at the University of Texas Health Science Center in San Antonio, TX as Associate Professor of Radiology, Vice Chair of Clinical Operations, Medical Director and Director of the Clinical Trials Division at the Radiology Department. He was formerly Director of Medical Development, Diagnostic Imaging and Associate Director of Clinical Development, Diagnostic Imaging for Bayer Healthcare (formerly Berlex Laboratories) in Montville, NJ. Dr. Gutiérrez also served as a medical monitor with Novartis (formerly Ciba-Geigy Labs) in Medellin. Dr. Gutiérrez has been the recipient of several awards for his work, and has been the lead researcher, international researcher and co-investigator on numerous clinical trials.  Regularly published, he has co-edited five medical books and authored or co-authored over 25 book chapters as well as 17 peer-reviewed articles and scores of abstracts and articles published in scientific research journals. Dr. Gutiérrez received a Doctorate in Medicine and Surgery from CES University in Medellin and Specialist in Clinical Radiology from Pontifical Xavierian University / San Ignacio Hospital in Bogota. He completed a research fellowship in Neuroradiology at Thomas Jefferson University / TJU Hospital in Philadelphia, PA and a visiting fellowship in Interventional Neuroradiology at the University of Miami / Jackson Memorial Hospital. Dr. Soto is Chairman of the Department of Radiology at Boston Medical Center and a Professor of Radiology at the Boston University School of Medicine. He has previously served as a general medical practitioner with the Hospital San Antonio de Prado in Colombia, section head of Body Imaging at University of San Vicente de Paúl Hospital, radiologist at CEDIMED in Medellin, assistant professor of Radiology at the University of Antioquia and was vice chairman of Boston Medical Center’s Department of Radiology for ten years. A native of Medellin with citizenship in both Colombia and the United States, Dr. Soto received his Doctor in Medicine and Surgery and Specialist in Diagnostic Radiology from CES University’s Health Sciences Institute in Medellin, and completed a Radiology Body Imaging Fellowship at Boston University Medical Center. Dr. Soto has received honors and awards from the Colombian Ministry of Education, Medellin Medicine Academy, Boston University Medical Center and numerous professional societies.  An extensively published researcher, Dr. Soto is a member of the editorial boards of Radiology and Abdominal Imaging, has edited seven books and has published over 85 original research papers and more than 35 reviews, book chapters and case reports. PharmaCielo Ltd. (the “Company”) is a global company privately held and headquartered in Canada, with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors.  The Company’s principal (and wholly-owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its Nursery and Propagation Centre located in Rionegro, Colombia. The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise.  PharmaCielo recognized the significant role that Colombia’s ideal location will play in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, has built a compelling business plan focused on supplying the international marketplace. This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as demand for the Company’s products, currency exchange changes and risks, internal funding and the financial condition of the Company, product roll-out, competition, technological changes, and other commercial matters involving the Company, its products, and the markets in which the Company operates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in subsequent reports should be consulted.


News Article | November 30, 2016
Site: globenewswire.com

TORONTO, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Dr. Patricio Stocker, President and CEO of PharmaCielo Ltd., announced the company has appointed a Medical Advisory Board (MAB) to provide guidance on the development of medicinal-grade cannabis oil extracts and related products appropriate for use by clinical practitioners. “Under the guidance of Dr. Delon Human, PharmaCielo Board of Directors member and Chair of the MAB, appointees will be able to provide significant input in the development of our medicinal-grade products through their ability to provide global expertise in the areas of healthcare policy, regulation, medical science and patient insights in addition to their clinical experience,” said Dr. Stocker. Dr. Human has assembled an experienced team of international medical clinicians whose expertise will be leveraged to provide guidance in the development of medicinal-grade cannabis oil based products, as well as international insight and understanding of worldwide healthcare policy and its implications for this emerging global industry. “The Medical Advisory Board will oversee PharmaCielo’s practices and processes, ensuring they are UN-aligned and performed ethically and according to Good Manufacturing and Good Medical Practice,” said Dr. Human.  “During the April 2016 UN General Assembly Special Session on Drugs, the UN and its member states strongly endorsed the need to ensure the accessibility and availability of internationally controlled drugs for medical and scientific purposes, including substances such as cannabinoids. In developing a global framework, this should be promoted within national legal systems, while simultaneously preventing diversion, abuse and trafficking. PharmaCielo has the opportunity to develop the world’s finest quality, naturally grown, pharma-grade cannabis oils.” Four appointees to the MAB were introduced (full biographies are available at www.pharmacielo.com): Dr. Delon Human is the president and CEO of Health Diplomats, a health advisory and consulting practice, providing strategic and technical advice on global health issues to Fortune 500 companies in the pharmaceutical, food, tobacco, nicotine and medical device industries as well as NGOs, governments and foundations. He has acted as adviser to WHO Director-Generals and UN Secretary-General Ban Ki Moon. He is a published author and specializes in global health strategy, corporate and product transformation, harm reduction and health communication. Formerly, he served as the Secretary-General of the International Food and Beverage Alliance (IFBA), which brings together the top food companies in the world. From 1997 to 2005, Dr. Human served as secretary general of the World Medical Association (WMA), the global representative body for physicians. He was instrumental in the establishment of the World Health Professions Alliance, an alliance of the global representative bodies of physicians, nurses, pharmacists, dentists and physical therapists. Dr. Human qualified as a physician in South Africa and completed his postgraduate studies in family medicine and child health in South Africa and Oxford, England. He was a clinician for two decades, part of the pediatric endocrinology research unit at the John Radcliffe Hospital and was involved in the establishment of several medical centers, a hospital and emergency clinic in South Africa. His business studies (MBA) were completed at the Edinburgh Business School. A former chair of the World Medical Association, Dr. Anders Milton is a highly sought-after consultant within the healthcare sector and has served as president of the European Regional Network on HIV/AIDS (ERNA) and as president of the Swedish Red Cross among a number of other positions, including appointment by the Swedish government as chairman of a committee on Swedish HIV/AIDS policies and a member of the Catastrophe Commission formed following the December 2004 tsunami. Recently he led a select committee studying organ donation and transplantation. Previously, Dr. Milton served as president and CEO of the Swedish Medical Association. A director of several public and privately held companies and foundations, Dr. Milton originally studied economics before turning to medicine, and after graduating university as a medical doctor and PhD he served as a clinician at the Department of Nephrology at the University Hospital at Uppsala. Throughout his career he has been engaged in work in support of human rights, ethics of medical practice and safe health care, of which effective pharmacotherapy is an integral part. Dr. Gutiérrez is a neuroradiologist in private practice and Director of the Neuroradiology Division at Centro Avanzado de Diagnostíco Médico (CEDIMED) in Colombia. Previously, Dr. Gutiérrez served at the University of Texas Health Science Center in San Antonio, TX as Associate Professor of Radiology, Vice Chair of Clinical Operations, Medical Director and Director of the Clinical Trials Division at the Radiology Department. He was formerly Director of Medical Development, Diagnostic Imaging and Associate Director of Clinical Development, Diagnostic Imaging for Bayer Healthcare (formerly Berlex Laboratories) in Montville, NJ. Dr. Gutiérrez also served as a medical monitor with Novartis (formerly Ciba-Geigy Labs) in Medellin. Dr. Gutiérrez has been the recipient of several awards for his work, and has been the lead researcher, international researcher and co-investigator on numerous clinical trials.  Regularly published, he has co-edited five medical books and authored or co-authored over 25 book chapters as well as 17 peer-reviewed articles and scores of abstracts and articles published in scientific research journals. Dr. Gutiérrez received a Doctorate in Medicine and Surgery from CES University in Medellin and Specialist in Clinical Radiology from Pontifical Xavierian University / San Ignacio Hospital in Bogota. He completed a research fellowship in Neuroradiology at Thomas Jefferson University / TJU Hospital in Philadelphia, PA and a visiting fellowship in Interventional Neuroradiology at the University of Miami / Jackson Memorial Hospital. Dr. Soto is Chairman of the Department of Radiology at Boston Medical Center and a Professor of Radiology at the Boston University School of Medicine. He has previously served as a general medical practitioner with the Hospital San Antonio de Prado in Colombia, section head of Body Imaging at University of San Vicente de Paúl Hospital, radiologist at CEDIMED in Medellin, assistant professor of Radiology at the University of Antioquia and was vice chairman of Boston Medical Center’s Department of Radiology for ten years. A native of Medellin with citizenship in both Colombia and the United States, Dr. Soto received his Doctor in Medicine and Surgery and Specialist in Diagnostic Radiology from CES University’s Health Sciences Institute in Medellin, and completed a Radiology Body Imaging Fellowship at Boston University Medical Center. Dr. Soto has received honors and awards from the Colombian Ministry of Education, Medellin Medicine Academy, Boston University Medical Center and numerous professional societies.  An extensively published researcher, Dr. Soto is a member of the editorial boards of Radiology and Abdominal Imaging, has edited seven books and has published over 85 original research papers and more than 35 reviews, book chapters and case reports. PharmaCielo Ltd. (the “Company”) is a global company privately held and headquartered in Canada, with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors.  The Company’s principal (and wholly-owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its Nursery and Propagation Centre located in Rionegro, Colombia. The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise.  PharmaCielo recognized the significant role that Colombia’s ideal location will play in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, has built a compelling business plan focused on supplying the international marketplace. This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as demand for the Company’s products, currency exchange changes and risks, internal funding and the financial condition of the Company, product roll-out, competition, technological changes, and other commercial matters involving the Company, its products, and the markets in which the Company operates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in subsequent reports should be consulted.


The International Association of HealthCare Professionals is pleased to welcome Bruce W. Cardone, MD, RVT, RPhS, Radiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly trained and qualified radiologist with a vast expertise in all facets of his work, especially diagnostic ultrasound, phlebology, and vascular medicine. Dr. Cardone has been in practice for more than 28 years and is currently serving patients at Vena – The Varicose Vein Institute in Waukesha, Wisconsin. Furthermore, he is affiliated with St. Mary’s Hospital and Mercy Hospital Medical Center. Dr. Cardone graduated with his Medical Degree in 1984 from the University of Turin in Turin, Italy, prior to completing his General Surgery internship at St. Francis Medical Center. He then went on to complete his residency in Diagnostic Radiology at Michael Reese Hospital in Chicago, before undertaking his fellowship at the Medical College of Wisconsin. Dr. Cardone is board certified by the American Board of Radiology, and remains an active member of the American Medical Association, the Radiological Society of North America, the American College of Phlebology, the Wisconsin Medical Society, and the Wisconsin Radiological Society. Additionally, he has earned the coveted title of Diplomate of the American Board of Phlebology. Dr. Cardone attributes his successful career to his education and perseverance. Learn more about Dr. Cardone by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit:http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Pooja Renjen, MD, Radiologist, to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Pooja Renjen is a highly trained and qualified radiologist with an extensive expertise in all facets of her work, especially pediatric radiology. Dr. Renjen has been in practice for more than 12 years and is currently serving patients within Pediatric Radiology in New York City, New York. She is also an Assistant Professor of Radiology at Weill Cornell Medical College, and an Assistant Attending Radiologist at New York-Presbyterian Hospital Weill Cornell Campus. Dr. Pooja Renjen earned her Bachelor’s Degree from Johns Hopkins University with a double major in Biology and Economics in 2000, and was elected Phi Beta Kappa upon graduation. She then attended New York University School of Medicine, where she graduated with her Medical Degree in 2004 and was inducted to the Alpha Omega Alpha. Following her graduation, Dr. Renjen completed her Internal Medicine internship at the Hospital of the University of Pennsylvania, where she remained for her Diagnostic Radiology residency, serving as Chief Resident. She then undertook her fellowship training in Pediatric Radiology at the prestigious Children’s Hospital of Philadelphia. Dr. Renjen is double board certified in both Diagnostic Radiology and Pediatric Radiology, and she is renowned as an expert pediatric radiologist. With an interest in international radiology outreach and education, Dr. Renjen spent time in both Botswana and Ethiopia and founded a radiology resident elective, and has participated in teaching a pediatric radiology fellowship. To keep up to date with the latest advances in her field, she maintains a professional membership with the Radiological Society of North America. She attributes her success to her family members, experience, and the opportunity to work with excellent doctors. In her free time, Dr. Renjen enjoys traveling. Learn more about Dr. Renje here: https://weillcornell.org/prenjen and be sure to read her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | February 15, 2017
Site: www.prweb.com

Diagnostic Center for Women has announced that Dr. Michael J. Plaza expands use of cryoablation treatment of fibroadenoma to include early stage breast cancer with the Visica® 2 Treatment System. Developed by Sanarus Technologies, the Visica 2 Treatment System is a cryoablation device that uses extreme cold (cryo) to destroy tissue (ablation). The device destroys the tumor by freezing and damaging the adjacent vasculature that fuels tumor growth. Dr. Michael J. Plaza is board-certified by the American Board of Radiology in Diagnostic Radiology. He completed his residency at University of Miami/Jackson Memorial Hospital and breast imaging fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Plaza has become the first radiologist in Miami to provide cryoablation for early stage breast cancer with the Visica 2 Treatment System. Cryoablation—also referred to as tumor freezing—is a minimally invasive procedure done under ultrasound guidance in the doctor’s office or radiology suite. After injection of local anesthesia, a thin probe is inserted through the skin directly into the tumor. Liquid nitrogen is pumped into the probe to form an “ice ball” around the lesion. Freezing destroys the tumor cells, which are then reabsorbed by the body over time. The procedure can be done in less than an hour with most patients reporting minimal discomfort and a resumption of normal activity right away. Little, if any, visible scarring occurs. Because no breast tissue is removed during the procedure, the natural shape of the breast is maintained. Dr. Plaza began using cryoablation for fibroadenoma in February 2016, and expanded to treating early stage breast cancer in October 2016. “We saw great results in treating benign breast tumors, and with the growing evidence in the medical literature, especially the National Cancer Institute Z1072 Trial we decided to expand our practice to include cryoablation of early stage breast cancer,” said Dr. Plaza. In a 5-year multicenter study funded by the National Cancer Institute and sponsored by the Alliance for Clinical Trials in Oncology, cryoablation with the Visica 2 Treatment System was shown to be 100% effective for complete ablation of invasive ductal breast cancer tumors <1.0 cm. The Visica 2 Treatment System was the exclusive device used in the Z1072 study and showed cryoablation to be effective in 92% of the targeted lesions. Results from this breast cancer study (ACOSOG Z1072), which included a 5-year follow-up, were published in the Annals of Surgical Oncology. “Cryoablation is an evolution in the treatment of early stage breast cancer. Unlike surgery, it is a minimally invasive procedure that preserves the shape of the breast and can be performed in the office under 30 minutes while the patient is awake” Dr. Plaza explains. “Patients can typically return to work the next day. I am excited to bring this modality to the patients in Miami.” Cryoablation with the Visica 2 Treatment System is a nonsurgical option for patients that have been diagnosed with early stage breast cancer, is visible on sonogram and has been confirmed with a biopsy. About Diagnostic Center for Women The Diagnostic Center For Women is a premier imaging facility focused on fostering female wellness. Established in 1999, they are committed to providing the most reliable and comprehensive testing available. Their facility is accredited in mammography, breast and body MRI and obstetric and gynecologic ultrasound by the following organizations: American College of Radiology (ACR), Mammography, Intersocietal Accreditation Commission (IAC), Breast MRI, Body MRI, and American Institute of Ultrasound Medicine (AIUM), Obstetric and Gynecologic Ultrasound. “At the Diagnostic Center for Women, we understand your unique health needs.” Find out more at http://www.dxforwomen.com About Sanarus Technologies In 2001, the Visica® 2 Treatment System was the first available for cryoablation of fibroadenomas. Since then, our system has been used to successfully treat thousands of patients. The Visica 2 Treatment System is FDA-cleared for the ablation of cancerous or malignant tissue and benign tumors. At Sanarus, we develop innovative solutions for the nonsurgical treatment of breast tumors. We are headquartered in Pleasanton, CA, and all of our products are manufactured in the USA. Find out more at http://www.sanarus.com


The International Association of HealthCare Professionals is pleased to welcome Gale A. Sisney, MD, FACR, Diagnostic Radiologist, to their prestigious organization with her upcoming publication in The Leading Physicians of the World. Dr. Gale A. Sisney is a highly trained and qualified radiologist with an extensive expertise in all facets of her work, especially breast imaging. Dr. Sisney has been in practice for more than 23 years and is currently serving patients within Global Radiology Outreach in Madison, Wisconsin. She is also serving patients within Radiology Mammography International. Dr. Sisney attended the University of Illinois at Chicago, graduating with her Medical Degree in 1988. Following her graduation, she subsequently completed her Diagnostic Radiology residency at Northwestern University Medical School, before undertaking her fellowship training in Breast Imaging and Intervention at the Swedish Medical Center: Radiology Imaging Associates. She has earned the coveted title of Fellow of the American College of Radiology. In addition to her clinical practice, Dr. Sisney is a lecturer for Herzing University, providing education and training for medical imaging and radiation therapy professionals. To keep up to date with the latest advances in her field, Dr. Sisney maintains professional memberships with the American College of Radiology, the Radiological Society of North America, the Association for American Women Radiologists, the Society of Breast Imaging, the American Roentgen Ray Society, and the Wisconsin Radiological Society. With her wealth of experience and knowledge, Dr. Sisney has been published extensively, and has appeared on several media, radio, and television broadcasts. Dr. Sisney attributes her success to her persistence. Learn more about Dr. Sisney by reading her upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Charif Abdul Rahman Sidani, MD, Radiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly trained and qualified radiologist with an extensive expertise in all facets of his work especially diagnostic radiology and neuroradiology. Dr. Sidani has been in practice for more than 13 years and is currently serving as Assistant Professor of Clinical Radiology within the University of Miami-Miller School of Medicine in Miami, Florida. He is also affiliated with Jackson Memorial Hospital. Dr. Sidani attended the American University of Beirut in Beirut, Lebanon, graduating with his Medical Degree in 2003. He subsequently completed an internship and Radiology residency within the same educational, before relocating to the United States and undertaking his fellowship training at the University of Miami/Jackson Memorial Medical Center. Dr. Sidani is double board certified in Neuroradiology and in Diagnostic Radiology by the American Board of Radiology. To keep up to date with the latest advances and developments in his field, Dr. Sidani maintains professional memberships with the American College of Radiology, the American Society for Neuroradiology, and the Lebanese Order of Physicians. With his wealth of experience and knowledge, Dr. Sidani is the recipient of numerous awards and recognitions, including the Henry H. Lerner MD Award for Teaching Excellence in 2014. He attributes his success to the support of his family, his excellent mentors, and hard work. When he is not assisting patients, Dr. Sidani enjoys playing soccer and spending time with his family. Learn more about Dr. Sidani here: http://www.med.miami.edu/ and be sure to read his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | February 15, 2017
Site: www.prweb.com

ROSELAND, N.J. — Author Patrick J. Conte, MD, PhD has pondered this question, “Is there a reason why we were born, and do we all have a purpose in life?” In his book, “Mysteries of Life, Death and Beyond” (published by Balboa Press), he attempts to answer it and hopefully guide readers on an amazing and somewhat mystical journey. He takes them from the creation of the known universe and through the time – space continuum of evolution, the effects of karmic interferences, the theory of reincarnation and the development and expressions of one’s emotional psyche. He accompanies them through the progression of the seven major energy centers of the body called chakras, which are in essence guide posts with instructions that help provide physical and spiritual fulfillment in order that they may enjoy all the wonderful experiences in this life and spiritual bliss in the next. “I believe that people are falling away from their religious beliefs and floundering around in seeking God or some higher power. People need to find out for themselves how to find their path in life. They need to be shown a roadmap so that they can find out for themselves how to live their lives and why,” Conte says. An enlightening and insightful read, “Mysteries of Life, Death and Beyond” will give readers a better understanding on where they came from and for what purpose. It will also help them get answers about matters concerning faith and assist people into finding their true spiritual self and what this life is all about. “Mysteries of Life, Death and Beyond” By Patrick J. Conte, MD, PhD Hardcover | 6x9in | 406 pages | ISBN 9781504359610 Softcover | 6x9in | 406 pages | ISBN 9781504359603 E-Book | 406 pages | ISBN 9781504360371 Available at Amazon and Barnes & Noble About the Author After graduating high school, Patrick J. Conte, MD, PhD attended the American Academy of Mortuary Science in New York City. Upon graduation, he was bestowed the Dean’s award. He was accepted into Stritch School of Medicine of Loyola University in Chicago, upon mustering out of active duty and without having to complete his fourth year of pre-med at Seton Hall. He is certified by the American Board of General Radiology, the American Board of Nuclear Medicine and the American Board of Diagnostic Radiology with Special Competence in Nuclear Radiology. He has been in practice for more than 40 years, and currently the Chief of Nuclear Medicine and senior attending radiologist at St. Joseph Regional Medical Center, Paterson. He is also the author of “Converging Paths of Ancient Ayurveda” and “Modern Medicine, A Western Physician’s Perspective.” For more information, interested parties may log on to patrickcontemd.com. Balboa Press, a division of Hay House, Inc. – a leading provider in publishing products that specialize in self-help and the mind, body, and spirit genres. Through an alliance with indie book publishing leader Author Solutions, LLC, authors benefit from the leadership of Hay House Publishing and the speed-to-market advantages of the self-publishing model. For more information, visit balboapress.com. To start publishing your book with Balboa Press, call 877-407-4847 today. For the latest, follow @balboapress on Twitter. ###

Loading Diagnostic Radiology collaborators
Loading Diagnostic Radiology collaborators